Brought to you by 
AbbVie, Genomics Medicine, Wuxi NextCODE sign 15-year genomics partnership
19 Jan 2021
Executive Summary
Under a 15-year collaboration, AbbVie Inc., Genomics Medicine Ireland Ltd. (GMI), and WuXi NextCODE Genomics are teaming up to perform population genomics research in Ireland with the goal of discovering and developing new therapies for diseases in the areas of oncology, neuroscience, and immunology.
Deal Industry
- Pharmaceuticals
- Research, Analytical Equipment & Supplies
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
-
Drug Discovery Tools
- Bioinformatics
Deal Status
- Final
Deal Type
-
Alliance
- R&D (No Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AbbVie, Genomics Medicine, Wuxi NextCODE sign 15-year genomics partnership
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice